Boundless Bio, Inc. (BOLD) community

BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$2.50+0.04 (+1.63%)

Close on Nov 13, 2026Market cap $56.87MP/E –Yield –

Community

Notes and questions about Boundless Bio from other investors

No posts about BOLD yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

See a number that looks wrong?